These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 407602)

  • 1. Specific inhibition of hypothalamic self-stimulation by selective reuptake blockade of either 5-hydroxytryptamine or noradrenaline.
    Atrens DM; Ungerstedt U; Ljungberg T
    Psychopharmacology (Berl); 1977 Apr; 52(2):177-80. PubMed ID: 407602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic and noradrenergic inhibition of hypothalamic self-stimulation: differentiation of reward and performance effects.
    Sinden JD; Atrens DM
    Eur J Pharmacol; 1982 Dec; 86(2):237-46. PubMed ID: 7160436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of reward and aversion processes in the rat diencephalon by neuroleptics: differential effects of clozapine and haloperidol.
    Atrens DM; Ljungberg T; Ungerstedt U
    Psychopharmacology (Berl); 1976 Aug; 49(1):97-100. PubMed ID: 822454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A.
    Waldmeier PC; Baumann PA; Wilhelm M; Bernasconi R; Maître L
    Eur J Pharmacol; 1977 Dec; 46(4):387-91. PubMed ID: 590347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-noradrenergic modulation of hypothalamic self-stimulation: studies employing clonidine, 1-phenylephrine and alpha-methyl-p-tyrosine.
    Hunt GE; Atrens DM; Chesher GB; Becker FT
    Eur J Pharmacol; 1976 May; 37(1):105-11. PubMed ID: 1278235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J
    Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine: selective inhibition of the aversive component of lateral hypothalamic self-stimulation.
    Atrens DM; Becker FT; Hunt GE
    Psychopharmacology (Berl); 1980; 71(1):97-9. PubMed ID: 6779330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tetracyclic antidepressant mianserin: evaluation of its blockade of presynaptic alpha-adrenoceptors in a self-stimulation model using clonidine.
    Hunt GE; Atrens DM; Johnson GF
    Eur J Pharmacol; 1981 Mar; 70(1):59-63. PubMed ID: 6111464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of adenylate cyclase and protein kinase C in the alpha 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices.
    Ramdine R; Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):386-95. PubMed ID: 2479843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine involvement in hippocampal self-stimulation.
    van der Kooy D; Fibiger HC; Phillips AG
    Brain Res; 1977 Nov; 136(1):119-30. PubMed ID: 145270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and self-stimulation: pharmacological differences between near- and far-lateral hypothalamic sites.
    Stephens DN; Herberg LJ
    Brain Res; 1975 Jun; 90(2):348-51. PubMed ID: 1139312
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.
    Herberg LJ; Stephens DN; Franklin KB
    Pharmacol Biochem Behav; 1976 May; 4(5):575-82. PubMed ID: 133356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline, dopamine, and brain-stimulation reward.
    Rolls ET; Kelly PH; Shaw SG
    Pharmacol Biochem Behav; 1974; 2(6):735-40. PubMed ID: 4463371
    [No Abstract]   [Full Text] [Related]  

  • 14. alpha-Adrenergic modulation of hypothalamic self-stimulation: effects of phenoxybenzamine, yohimbine, dexamphetamine and their interactions with clonidine.
    Hunt GE; Atrens DM; Becker FT; Paxinos G
    Eur J Pharmacol; 1978 Dec; 53(1):1-8. PubMed ID: 216557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of noradrenaline of the dorsal hippocampus in the mechanism of self-stimulation reaction in rats].
    Gasanov GG; Melikov EM; Movsumov GD
    Biull Eksp Biol Med; 1990 Jan; 109(1):5-6. PubMed ID: 2110487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-induced attenuation of brain stimulation reward in rats.
    Fouriezos G; Hansson P; Wise RA
    J Comp Physiol Psychol; 1978 Aug; 92(4):661-71. PubMed ID: 29060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraventricular 6-hydroxydopamine and replacement therapy with norepinephrine, dopamine, and serotonin on self-stimulation in diencephalic and mesencephalic regions in the rat.
    Olds ME
    Brain Res; 1975 Nov; 98(2):327-42. PubMed ID: 1182523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat.
    Kelley SP; Hodge CW
    Pharmacol Biochem Behav; 2003 Jan; 74(2):297-302. PubMed ID: 12479948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of psychotropic drugs on hypothalamic self-stimulation behavior in rats.
    Kamei C; Masuda Y; Shimizu M
    Jpn J Pharmacol; 1974 Aug; 24(4):613-9. PubMed ID: 4455970
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain.
    Bruinvels J
    Br J Pharmacol; 1971 Jun; 42(2):281-6. PubMed ID: 5091160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.